RESEARCH TRIANGLE PARK, NC--(Marketwire - December 13, 2007) - SCYNEXIS, Inc. announced today that it has earned a payment for meeting certain milestones in its multi-year research collaboration with Merial Limited, which began in 2005. SCYNEXIS, a premier drug discovery and development company, focuses considerable medicinal chemistry, advanced biological screening, bioanalytical and ADMET efforts towards Merial’s animal health discovery efforts.
